By Professor Emad El-Omar

Journal articles

De Sanjose S; Dickie A; Alvaro T; Romagosa V; Garcia Villanueva M; Domingo-Domenech E; Fernandez De Sevilla A; El-Omar E, 2004, 'Helicobacter pylori and malignant lymphoma in Spain', Cancer Epidemiology Biomarkers and Prevention, 13, pp. 944 - 948

El-Omar EM, 2004, 'The role of interleukin-1 beta in Helicobacter pylori-associated disease', Netherlands Journal of Medicine, 62, pp. 47 - 52

Zambon CF; Basso D; Navaglia F; Falda A; Belluco C; Fogar P; Greco E; Gallo N; Farinati F; Cardin R; Rugge M; Di Mario F; Plebani M; El-Omar EM; Rabkin CS; Chow WH, 2004, 'Increased Risk of Noncardia Gastric Cancer Associated with Proinflammatory Cytokine Gene Polymorphisms [11] (multiple letters)', Gastroenterology, 126, pp. 382 - 383, http://dx.doi.org/10.1053/j.gastro.2003.08.042

Macarthur M; Hold GL; El-Omar EM, 2004, 'Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy', American Journal of Physiology - Gastrointestinal and Liver Physiology, 286, http://dx.doi.org/10.1152/ajpgi.00475.2003

Furuta T; Shirai N; Xiao F; El-Omar EM; Rabkin CS; Sugimura H; Ishizaki T; Ohashi K, 2004, 'Polymorphism of interleukin-1β affects the eradication rates of Helicobacter pylori by triple therapy', Clinical Gastroenterology and Hepatology, 2, pp. 22 - 30, http://dx.doi.org/10.1016/S1542-3565(03)00288-X

El-Omar EM; Rabkin CS; Chow W-H, 2004, 'Reply', Gastroenterology, 126, pp. 383 - 384, http://dx.doi.org/10.1053/j.gastro.2003.11.033

El-Omar EM; Rabkin CS; Gammon MD; Vaughan TL; Risch HA; Schoenberg JB; Stanford JL; Mayne ST; Goedert J; Blot WJ; Fraumeni JF; Wong-Ho C, 2003, 'Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms', Gastroenterology, 124, pp. 1193 - 1201, http://dx.doi.org/10.1016/S0016-5085(03)00157-4

Garza-González E; Hold G; Pérez-Pérez GI; Bosques-Padilla FJ; Tijerina-Menchaca R; Maldonado-Garza HJ; el-Omar E, 2003, 'Role of polymorphism of certain cytokines in gastric cancer in Mexico. Preliminary results', Revista de gastroenterología de México, 68, pp. 107 - 112

Troost E; Hold GL; Smith MG; Chow WH; Rabkin CS; McColl KEL; El-Omar EM, 2003, 'The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk.', Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 17 Suppl B, http://dx.doi.org/10.1155/2003/397060

McColl KEL; El-Omar E; Pharoah P; Caldas C; Huntsman D, 2002, 'E-cadherin germline mutations and risk of gastric cancer [1] (multiple letters)', Gastroenterology, 123, pp. 1406 - 1407, http://dx.doi.org/10.1053/gast.2002.36382

Hisada M; Gold B; Kim N; Owens M; Cranston B; El-Omar E; Hanchard B, 2002, 'Risk factors of Helicobacter pylori infection in the Jamaica mother-infant cohort study', AMERICAN JOURNAL OF EPIDEMIOLOGY, 155, pp. s105 - s105, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000175955500411&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Takata T; El-Omar E; Camorlinga M; Thompson SA; Minohara Y; Ernst PB; Blaser MJ, 2002, 'Helicobacter priori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ mice', Infection and Immunity, 70, pp. 3073 - 3079, http://dx.doi.org/10.1128/IAI.70.6.3073-3079.2002

Furuta T; Elomar EM; Xiao F; Shirai N; Takashima M; Sugimurra H, 2002, 'Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan', Gastroenterology, 123, pp. 92 - 105, http://dx.doi.org/10.1053/gast.2002.34156

El-Omar EM; Malfertheiner P, 2001, 'Helicobacter pylori infection and gastric cancer', Current Opinion in Gastroenterology, 17

El-Omar EM; Carrington M; Chow WH; McColl KEL; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer', Nature, 412, pp. 99, http://dx.doi.org/10.1038/35083631

El-Omar EM; Carrington M; Chow WH; McColl KE; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.', Nature, 412, pp. 99

El-Omar EM, 2001, 'The importance of interleukin 1 β in Helicobacter pylori associated disease', Gut, 48, pp. 743 - 747, http://dx.doi.org/10.1136/gut.48.6.743

McColl KEL; Murray LS; Gillen D; Dickson A; Fletcher J; Henry E; Kelman A; El-Omar E; Hilditch T, 2001, 'Non-invasive HP testing versus endoscopy with HP testing for dyspepsia', GUT, 48, pp. A14 - A15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167334700053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

El-Omar EM, 2001, 'Cytokine gene polymorphisms and risk of gastric cancer', Japanese Journal of Gastroenterology, 98, pp. A303 - A305, http://dx.doi.org/10.11405/nisshoshi1964.98.87sokai_A303

El-Omar EM; Chow WH; Rabkin CS, 2001, 'Gastric cancer and H. pylori: Host genetics open the way', Gastroenterology, 121, pp. 1002 - 1004, http://dx.doi.org/10.1053/gast.2001.28739

El-Omar EM; You W-C; Chow W-H; Fraumeni JF; Rabkin CS, 2001, 'IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China', Gastroenterology, 120, pp. A743 - A743, http://dx.doi.org/10.1016/s0016-5085(08)83701-8

McColl KEL; Murray LS; Gillen D; Dickson A; Fletcher J; Henry E; Kelman AW; El-Omar EM; Hilditch TE, 2001, 'Non-invasive H. pylori testing versus endoscopy with H. pylori testing for dyspepsia', Gastroenterology, 120, pp. A238 - A238, http://dx.doi.org/10.1016/s0016-5085(08)81180-8

El-Omar EM; Chow W-H; Gammon MD; Vaughan TL; Risch HA; Fraumeni JF, 2001, 'Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas', Gastroenterology, 120, pp. A86 - A86, http://dx.doi.org/10.1016/s0016-5085(08)80425-8

El-Omar E; McColl KEL, 2000, 'When enthusiasm is infectious - Reply', GASTROENTEROLOGY, 119, pp. 276 - 276, http://dx.doi.org/10.1016/S0016-5085(00)70071-0

El-Omar EM; Carrington M; Chow WH; McColl KEL; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS, 2000, 'Interleukin-1 polymorphisms associated with increased risk of gastric cancer', Nature, 404, pp. 398 - 402, http://dx.doi.org/10.1038/35006081

McColl KEL; El-Omar E; Gillen D, 2000, 'Helicobacter pylori gastritis and gastric physiology', Gastroenterology Clinics of North America, 29, pp. 687 - 703, http://dx.doi.org/10.1016/S0889-8553(05)70138-2

El-Omar EM; Oien K; Murray LS; El-Nujumi A; Wirz A; Gillen D; Williams C; Fullarton G; McColl KEL, 2000, 'Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H-pylori', GASTROENTEROLOGY, 118, pp. 22 - 30, http://dx.doi.org/10.1016/S0016-5085(00)70410-0

McColl KEL; Dickson A; El-Nujumi A; El-Omar E; Kelman A, 2000, 'Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease', American Journal of Gastroenterology, 95, pp. 101 - 105, http://dx.doi.org/10.1016/S0002-9270(99)00765-0

McColl KEL; Gillen D; El-Omar E, 2000, 'The role of gastrin in ulcer pathogenesis', Bailliere's Best Practice and Research in Clinical Gastroenterology, 14, pp. 13 - 26, http://dx.doi.org/10.1053/bega.1999.0056

Palli D; Masala G; Russo A; Saieva C; Bazzoli F; Brenner H; Bode G; Boeing H; Parsonnet J; El-Omar E; McColl KEL, 2000, 'When enthusiasm is infectious [1] (multiple letters)', Gastroenterology, 119, pp. 274 - 276, http://dx.doi.org/10.1053/gast.2000.9116

El-Omar EM; Wang C-D; McColl KE; Rabkin CS, 2000, 'Interleukin-10 promoter polymorphisms influence risk of chronic H. pylori infection', Gastroenterology, 118, pp. A889 - A889, http://dx.doi.org/10.1016/s0016-5085(00)85694-2

El-Omar EM; Chow W-HM; McColl KE; Fraumeni JF; Rabkin CS, 2000, 'Interleukin-1B-enhancing genotypes are associated with increased risk of gastric cancer and its precursors', Gastroenterology, 118, pp. A181 - A181, http://dx.doi.org/10.1016/s0016-5085(00)82800-0

Lieber CS; Puspok A; Oberhubek G; Logan RFA; Logan RPH; Ganz PA; Scott BB; McColl KEL; Murray LS; El-Omar EM; Blum AL; Talley NJ; Stolte M; Friedman LS, 1999, 'Helicobacter pylori and nonulcer dyspepsia [1] (multiple letters)', New England Journal of Medicine, 340, pp. 1508 - 1511, http://dx.doi.org/10.1056/NEJM199905133401912

Smith AD; Gillen D; Cochran KM; El-Omar E; McColl KEL, 1999, 'Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers', American Journal of Gastroenterology, 94, pp. 1209 - 1213, http://dx.doi.org/10.1016/S0002-9270(99)00124-0

Mccoll KEL; Dickson A; El-Nujumi A; El-Omar E; Kelman A, 1999, 'Symptomatic benefit 1-3 years post H-pylori eradication in ulcer patients: Impact of reflux disease', GUT, 44, pp. A120 - A120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079446300478&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McColl KEL; Murray LS; El-Omar EM, 1999, 'Reply', Gastroenterology, 117, pp. 271 - 272, http://dx.doi.org/10.1016/s0016-5085(99)70580-9

McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T, 1998, 'Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia', New England Journal of Medicine, 339, pp. 1869 - 1874, http://dx.doi.org/10.1056/NEJM199812243392601

McColl KEL; Gillen D; El-Omar E; Ardill J, 1998, 'Effect of antral atrophy on gastric function in h. pylori infection: Relevance to progression to pangastritis', Zeitschrift fur Gastroenterologie, 36, pp. 1090

El-Omar E; Oien K; El-Nujumi A; Wirz A; Gillen D; Williams C; Ardill JES; Fullarton G; McColl KEL, 1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GASTROENTEROLOGY, 114, pp. A590 - A590, http://dx.doi.org/10.1016/S0016-5085(98)82402-5

McColl KEL; Murray LS; El-Omar E; Kelman AW; Dickson A; El-Nujumi A; Wirz A; Knill-Jones R; Penney C; Cochrane K; Danesh B; Gaw N; Wilson F, 1998, 'UK MRC trial of H-pylori eradication therapy for non-ulcer ulcer dyspepsia.', GASTROENTEROLOGY, 114, pp. A222 - A222, http://dx.doi.org/10.1016/S0016-5085(98)80900-1

McColl KEL; El-Omar E; Gillen D; Oien K, 1998, 'H-pylori-associated hypochlorhydria - Reply', GASTROENTEROLOGY, 114, pp. 620 - 621, http://dx.doi.org/10.1016/S0016-5085(98)70559-1

El-Omar E; Oien K; El-Nujumi A; Wirz A; Gillen D; Williams C; Ardill JES; Fullarton G; Mccoll KEL, 1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GUT, 42, pp. A51 - A51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mccoll KEL; Murray LS; El-Omar E; Kelman AW; Dickson A; El-Nujumi A; Wirz A; Knill-Jones R; Penney C; Cochrane K; Danesh B; Gaw N; Wilson F, 1998, 'UK MRC trial of H-pylori eradication therapy for non-ucler dyspepsia', GUT, 42, pp. A3 - A3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McColl KEL; El-Nujumi A; Murray LS; El-Omar EM; Dickson A; Kelman AW; Hilditch TE, 1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', Gut, 42, pp. 618 - 622, http://dx.doi.org/10.1136/gut.42.5.618

Beales ILP; McColl KEL; El-Omar E; Gillen D; Oien K, 1998, 'H. pylori-associated hypochlorhydria [2] (multiple letters)', Gastroenterology, 114, pp. 618 - 620, http://dx.doi.org/10.1016/s0016-5085(98)70558-x

McColl KEL; El-Omar E; Gillen D, 1998, 'Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy', British Medical Bulletin, 54, pp. 121 - 138, http://dx.doi.org/10.1093/oxfordjournals.bmb.a011663

Gillen D; El-Omar EM; Wirz AA; Ardill JES; McColl KEL, 1998, 'The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects', Gastroenterology, 114, pp. 50 - 57, http://dx.doi.org/10.1016/S0016-5085(98)70632-8

McColl KEL; EI-Nujumi A; Murray LS; El-Omar EM; Dickson A; Kelman AW; Hilditch TE, 1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', European Journal of Gastroenterology & Hepatology, 10, pp. 626 - 626, http://dx.doi.org/10.1097/00042737-199807000-00025

McColl KEL; El-Omar EM; Gillen D, 1997, 'Alterations in gastric physiology in Helicobacter pylori infection: Causes of different diseases or all epiphenomena?', Italian Journal of Gastroenterology and Hepatology, 29, pp. 459 - 464

McColl KEL; El-Omar E; Gillen D; Banerjee S, 1997, 'The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer', Seminars in Gastrointestinal Disease, 8, pp. 142 - 155

Back to profile page